The latest closing stock price for Rapt Therapeutics as of November 07, 2024 is 3.10.
An investor who bought $1,000 worth of Rapt Therapeutics stock at the IPO in 2019 would have $-756 today, roughly -1 times their original investment - a -24.58% compound annual growth rate over 5 years.
The all-time high Rapt Therapeutics stock closing price was 48.86 on January 27, 2020.
The Rapt Therapeutics 52-week high stock price is 27.35, which is 782.3% above the current share price.
The Rapt Therapeutics 52-week low stock price is 1.64, which is 47.1% below the current share price.
The average Rapt Therapeutics stock price for the last 52 weeks is 8.92.
An investor who bought $1,000 worth of Rapt Therapeutics stock at the IPO in 2019 would have $-756 today, roughly -1 times their original investment - a -24.58% compound annual growth rate over 5 years.
The all-time high Rapt Therapeutics stock closing price was 48.86 on January 27, 2020.
The Rapt Therapeutics 52-week high stock price is 27.35, which is 782.3% above the current share price.
The Rapt Therapeutics 52-week low stock price is 1.64, which is 47.1% below the current share price.
The average Rapt Therapeutics stock price for the last 52 weeks is 8.92.